## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 2.32 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($157.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 4, Bearish: 1)

**1. C.H. Robinson Worldwide To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday**
- Source: Benzinga | 20251224T171649 | Bullish | Relevance: 100%
- This article presents a summary of recent analyst ratings for ten different companies, including C.H. Robinson Worldwide, CECO Environmental, and Americold Realty Trust. Analysts have adjusted price targets and ratings based on their outlook for these companies, with some seeing potential for significant rallies while others face downgrades. The article provides specific details on price target changes and maintained ratings for each company.

**2. C.H. Robinson is the AI leader in the global logistics sector - BofA (CHRW:NASDAQ)**
- Source: Seeking Alpha | 20251224T152543 | Bullish | Relevance: 100%
- Bank of America reiterated its bullish stance on C.H. Robinson Worldwide (CHRW), citing the company's widening moat in the global logistics sector. Analyst Ken Hoexter and his team believe C.H. Robinson is an AI leader with an improving outlook.

**3. Voya Investment Management LLC Has $10.98 Million Stock Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251223T134049 | Bullish | Relevance: 100%
- Voya Investment Management LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) during the third quarter, boosting its holdings by 126.3% to 82,941 shares valued at $10.98 million. This comes as C.H. Robinson reported better-than-expected Q3 EPS of $1.40, a dividend increase to $0.63 per share, and received a "Moderate Buy" consensus rating from analysts with an average price target of $147.48. Despite recent insider stock sales totaling approximately $14.3 million, institutional investors and hedge funds collectively own 93.15% of the company's stock.

**4. Exchange Traded Concepts LLC Has $11.66 Million Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251223T094355 | Bullish | Relevance: 100%
- Exchange Traded Concepts LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) during the third quarter, now holding shares valued at $11.66 million. This comes amidst several analyst upgrades and an increased dividend payout, though company insiders have recently sold off a substantial number of shares.

**5. Is It Too Late To Consider C.H. Robinson After Its Strong 2025 Share Price Rally?**
- Source: Yahoo Finance | 20251222T100906 | Bearish | Relevance: 100%
- C.H. Robinson Worldwide has seen significant share price growth in 2025, outpacing the market, driven by optimism around freight efficiency and digital logistics. However, valuation checks suggest the stock is currently overvalued, with its DCF analysis indicating a 14.2% overvaluation and its PE ratio sitting well above industry averages and its proprietary Fair Ratio. Investors are encouraged to consider different "Narratives" for valuation to align with their own views on the company's future.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-24 | B of A Securiti | $182 | $167 | +9% |
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-24 | B of A Securiti | main | Buy |
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +19%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.32 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (4 raises, avg +19%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.5B |
| Beta | 0.91 |
| 52W Range | $84.68 - $167.90 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.32 |
| Forward P/E | 27.5 |
| Current P/E | 33.0 |
| YoY Growth | 20.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 5.7% to 0.3% (-5.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 (-1.1%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.30% (CS: 78) | Neutral |
| RSI_14 | 65.8 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.101x | Above |
| vs SMA200 | 1.403x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.95
- **Stop Loss:** $157.81 (4.3% risk)
- **Target:** $172.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $20,783.70
- **Portfolio %:** 20.78%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*